Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

AC Immune SA (ACIU)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.4100+0.1600 (+4.92%)
At close: 04:00PM EDT
3.4100 0.00 (0.00%)
After hours: 04:02PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 8/15/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 312.6100
52 Week Low 32.0600
50-Day Moving Average 33.3097
200-Day Moving Average 34.1995

Share Statistics

Avg Vol (3 month) 383.54k
Avg Vol (10 day) 340.94k
Shares Outstanding 572.65M
Implied Shares Outstanding 6N/A
Float 833.1M
% Held by Insiders 152.06%
% Held by Institutions 118.79%
Shares Short (Jul 14, 2022) 4437.66k
Short Ratio (Jul 14, 2022) 43.94
Short % of Float (Jul 14, 2022) 41.11%
Short % of Shares Outstanding (Jul 14, 2022) 40.52%
Shares Short (prior month Jun 14, 2022) 4458.04k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CHF.

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-23.88%
Return on Equity (ttm)-38.60%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-62.28M
EBITDA -79.88M
Net Income Avi to Common (ttm)-75.68M
Diluted EPS (ttm)-1.0700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)154.15M
Total Cash Per Share (mrq)1.8
Total Debt (mrq)2.63M
Total Debt/Equity (mrq)1.29
Current Ratio (mrq)13.28
Book Value Per Share (mrq)2.46

Cash Flow Statement

Operating Cash Flow (ttm)-74.95M
Levered Free Cash Flow (ttm)-47.72M
Advertisement
Advertisement